299 related articles for article (PubMed ID: 25573764)
1. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China.
Bao XY; Duan L; Yang WZ; Li DS; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2015; 39(2):75-81. PubMed ID: 25573764
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya disease in China: its clinical features and outcomes.
Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
[TBL] [Abstract][Full Text] [Related]
5. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
6. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
8. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
9. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease.
Noh HJ; Kim SJ; Kim JS; Hong SC; Kim KH; Jun P; Bang OY; Chung CS; Lee KH; Lee KH; Kim GM
J Neurol Sci; 2015 Dec; 359(1-2):381-8. PubMed ID: 26671146
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.
Guzman R; Lee M; Achrol A; Bell-Stephens T; Kelly M; Do HM; Marks MP; Steinberg GK
J Neurosurg; 2009 Nov; 111(5):927-35. PubMed ID: 19463046
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India.
Sundaram S; Sylaja PN; Menon G; Sudhir J; Jayadevan ER; Sukumaran S; Sreedharan SE; Sarma S
J Neurol Sci; 2014 Jan; 336(1-2):99-102. PubMed ID: 24183032
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
17. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease.
Funaki T; Takahashi JC; Takagi Y; Yoshida K; Araki Y; Kikuchi T; Kataoka H; Iihara K; Miyamoto S
J Neurosurg Pediatr; 2013 Dec; 12(6):626-32. PubMed ID: 24138143
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
20. Clinical features, surgical treatment, and long-term outcomes of moyamoya disease in a single institution of Fujian, Southeast China: A retrospective study.
Ding YH; Chen JY; Zheng ES; Wang ZQ; Liang RS; Shi SS; Tu XK
Medicine (Baltimore); 2023 Oct; 102(43):e35684. PubMed ID: 37904447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
